| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6108395 | Journal of Hepatology | 2008 | 8 Pages |
Abstract
Lower rates of resistance to lamivudine, lower serum HBV DNA levels and higher rates of ALT normalization were seen in the combination therapy group after two years. However, serological outcomes were similar.
Keywords
hepatitis B e-antigenCHBULNHBsAgHBeAgALTDNAadefovir dipivoxilaspartateAlanine aminotransferasedeoxyribonucleic acidITTTyrosineUpper limit of normalCombination therapyAnti-HBeAnti-HBsIntent to treatLamivudineMethioninechronic hepatitis BHBVpolymerase chain reactionPCRHIVhuman immunodeficiency virushepatitis B virusonce daily
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Joseph J.Y. Sung, Jak-Yiu Lai, Stefan Zeuzem, Wan Chen Chow, E. Jenny Heathcote, Robert P. Perrillo, Carol L. Brosgart, Mary A. Woessner, Susan A. Scott, D. Fraser Gray, Stephen D. Gardner,